CN
Carmine N. Stengone sold $160K of CTNM stock
Carmine N. Stengone, CEO and President of Contineum Therapeutics, Inc. (CTNM), sold 10,000 shares of CTNM stock worth $160K, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 1 day before it was made public.
CTNM has moved -44.8% since the trade date, from $16.39 to $9.04 (Nov 19, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 1 day
- Price since
- -44.8%
- Role
- CEO and President
- Source
- SEC Form 4